Literature DB >> 25150584

Hand therapist use of patient report outcome (PRO) in practice: a survey study.

Kristin Valdes1, Joy MacDermid2, Lori Algar3, Brian Connors4, Lisa M Cyr5, Sharon Dickmann6, Ann M Lucado7, Nancy Naughton8.   

Abstract

PURPOSE: The purpose of this survey was to gain greater insight into hand therapists' use of Patient Report Outcome (PRO) measures.
METHODS: An 11-question survey that evaluated therapists' perceptions, preferences, and patterns of use of patient report outcome measures was sent to members of ASHT.
RESULTS: A total of 633 ASHT members participated in the survey study. A large majority of participants (92%) responded affirmatively to using a PRO measure in practice. The DASH was reported as the most frequently used measure (90%). The majority of therapists (84%) discuss the results of the outcome measurement score with their patients. Of the participants who use more than one outcome measure, 44% report that this allows them to better establish their patient's functional and physical limitations.
CONCLUSION: The findings in this study suggest that a large percentage of hand therapists are currently including a PRO measure in their hand therapy practice.
Copyright © 2014 Hanley & Belfus. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hand; Measurement; Outcome; Practice; Survey; Therapist

Mesh:

Year:  2014        PMID: 25150584     DOI: 10.1016/j.jht.2014.07.001

Source DB:  PubMed          Journal:  J Hand Ther        ISSN: 0894-1130            Impact factor:   1.950


  3 in total

1.  Validity and interpretability of the QuickDASH in the assessment of hand disability in rheumatoid arthritis.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Sonia Farah
Journal:  Rheumatol Int       Date:  2018-12-03       Impact factor: 2.631

2.  CUPID: a protocol of a randomised controlled trial to identify characteristics of similar Chinese patent medicines.

Authors:  Hongbo Cao; Jingbo Zhai; Nan Li; Hongxia Cao; Xiang Lei; Wei Mu; Zhi Liu; Hui Wang; Hongcai Shang
Journal:  BMJ Open       Date:  2014-11-27       Impact factor: 2.692

3.  Naoxuekang, Xinnaoshutong and Xuesaitong capsules for treating stroke: a protocol for a randomised controlled trial.

Authors:  Huiling Chen; Hongbo Cao; Xu Guo; Meidan Zhao; Qing Xia; Bo Chen; Tieniu Zhao; Wenyuan Gao
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.